MKI67 and pancreatic adenocarcinoma: Furthermore, the level of MKI67 expression significantly differed in disease-free survival and overall survival with PADD (pancreatic adenocarcinoma), SARC (sarcoma), and UVM (uveal melanoma) (Additional file 1: Figure S2A–C).